Retour
Fourchette du Jour
15,94 €
15,94 €
Fourchette 52 Semaines
11,16 €
17,54 €
Volume
100
Moyenne 50J / 200J
16,37 €
/
14,41 €
Clôture Précédente
15,90 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 35,6 | 0,2 |
| P/B | 2,2 | 3,0 |
| ROE % | 7,4 | 3,6 |
| Net Margin % | 4,4 | 3,8 |
| Rev Growth 5Y % | 10,7 | 9,9 |
| D/E | 2,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,50 €
0,48 € – 0,53 €
|
1,17B | 1 |
| FY2026 |
0,44 €
0,42 € – 0,46 €
|
1,14B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-19 | N/A | 0,10 € | — |
| 2025-08-12 | N/A | 0,04 € | — |
| 2025-05-06 | N/A | 0,13 € | — |
| 2025-02-18 | N/A | 0,07 € | — |
| 2024-11-11 | N/A | 0,05 € | — |
| 2024-08-08 | N/A | 0,06 € | — |
| 2024-05-09 | N/A | 0,20 € | — |
| 2024-02-20 | N/A | 0,00 € | — |
Dividend History
7 yr streakYield
0,04%
Payout Ratio
1,52%
Growth (3Y)
-2,21%
Growth (5Y)
-0,78%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Apr 15, 2026 | 0,06 € | 4,26% |
| Feb 27, 2026 | Mar 13, 2026 | 0,06 € | 3,90% |
| Jan 30, 2026 | Feb 13, 2026 | 0,06 € | 4,29% |
| Dec 31, 2025 | Jan 15, 2026 | 0,06 € | 4,48% |
| Nov 28, 2025 | Dec 15, 2025 | 0,06 € | 4,49% |
| Oct 31, 2025 | Nov 14, 2025 | 0,06 € | 5,00% |
| Sep 30, 2025 | Oct 15, 2025 | 0,06 € | 4,95% |
| Aug 29, 2025 | Sep 15, 2025 | 0,06 € | 5,19% |
| Jul 31, 2025 | Aug 15, 2025 | 0,06 € | 5,18% |
| Jun 30, 2025 | Jul 15, 2025 | 0,06 € | 4,95% |
| May 30, 2025 | Jun 13, 2025 | 0,06 € | 5,12% |
| Apr 30, 2025 | May 15, 2025 | 0,06 € | 5,54% |
| Mar 31, 2025 | Apr 15, 2025 | 0,05 € | 5,83% |
| Feb 28, 2025 | Mar 14, 2025 | 0,05 € | 5,89% |
| Jan 31, 2025 | Feb 14, 2025 | 0,05 € | 6,19% |
| Dec 31, 2024 | Jan 15, 2025 | 0,05 € | 6,27% |
| Nov 29, 2024 | Dec 13, 2024 | 0,06 € | 5,70% |
| Oct 31, 2024 | Nov 15, 2024 | 0,06 € | 5,50% |
| Sep 30, 2024 | Oct 15, 2024 | 0,06 € | 5,55% |
| Aug 30, 2024 | Sep 13, 2024 | 0,06 € | 6,10% |
Points Clés
Revenue grew 10,71% annually over 5 years — strong growth
Earnings grew 15,85% over the past year
Negative free cash flow of -42,83M
P/E of 35,61 — premium valuation
ROIC of 3,40% — low return on invested capital
Croissance
Revenue Growth (5Y)
10,71%
Revenue (1Y)12,42%
Earnings (1Y)15,85%
FCF Growth (3Y)N/A
Qualité
Return on Equity
7,42%
ROIC3,40%
Net Margin4,43%
Op. Margin9,68%
Sécurité
Debt / Equity
1,99
Current Ratio0,51
Interest Coverage2,15
Valorisation
P/E Ratio
35,61
Forward P/E36,38
P/B Ratio2,20
EV/EBITDA29,75
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,42% | Revenue Growth (3Y) | 13,07% |
| Earnings Growth (1Y) | 15,85% | Earnings Growth (3Y) | 151,43% |
| Revenue Growth (5Y) | 10,71% | Earnings Growth (5Y) | 21,16% |
| Profitability | |||
| Revenue (TTM) | 1,00B | Net Income (TTM) | 44,49M |
| ROE | 7,42% | ROA | 1,76% |
| Gross Margin | 13,97% | Operating Margin | 9,68% |
| Net Margin | 4,43% | Free Cash Flow (TTM) | -42,83M |
| ROIC | 3,40% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,99 | Current Ratio | 0,51 |
| Interest Coverage | 2,15 | ||
| Dividends | |||
| Dividend Yield | 0,04% | Payout Ratio | 1,52% |
| Dividend Growth (3Y) | -2,21% | Dividend Growth (5Y) | -0,78% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 35,61 | Forward P/E | 36,38 |
| P/B Ratio | 2,20 | P/S Ratio | 1,58 |
| PEG Ratio | -4,48 | Forward PEG | N/A |
| EV/EBITDA | 29,75 | Fwd EV/EBITDA | 17,18 |
| Forward P/S | 1,39 | Fwd Earnings Yield | 2,75% |
| FCF Yield | -2,70% | ||
| Market Cap | 1,58B | Enterprise Value | 2,89B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,00B | 893,16M | 785,37M | 718,59M | 668,49M |
| Net Income | 44,49M | 38,40M | 7,04M | 10,67M | 20,65M |
| EPS (Diluted) | 0,48 | 0,53 | 0,10 | 0,15 | 0,31 |
| Gross Profit | 140,24M | 893,16M | 146,31M | 91,00M | 81,85M |
| Operating Income | 97,24M | 103,19M | 115,40M | 38,04M | 56,83M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,53B | 1,86B | 1,70B | 1,68B | 1,61B |
| Total Liabilities | 1,82B | 1,38B | 1,32B | 1,25B | 1,20B |
| Shareholders' Equity | 718,94M | 480,72M | 373,77M | 434,69M | 405,85M |
| Total Debt | 1,43B | 1,01B | 1,01B | 977,96M | 950,28M |
| Cash & Equivalents | 119,56M | 127,20M | 24,40M | 38,05M | 29,05M |
| Current Assets | 177,73M | 164,87M | 60,70M | 83,76M | 95,74M |
| Current Liabilities | 351,15M | 388,11M | 508,46M | 336,71M | 230,47M |